{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:10:08Z","timestamp":1759972208400,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal des Maladies Vasculaires"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.jmv.2010.08.004","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T05:04:19Z","timestamp":1286168659000},"page":"348-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["La thrombocytose au cours des traitements par h\u00e9parine de bas poids mol\u00e9culaire\u00a0: une situation plus fr\u00e9quente qu\u2019on ne le croit\u00a0?"],"prefix":"10.1016","volume":"35","author":[{"given":"M.","family":"Lambert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Trillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cooren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Glantenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Jude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-Y.","family":"Hatron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmv.2010.08.004_bib0005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1160\/TH08-10-0659","article-title":"Heparin-induced thrombocytopenia: what clinicians need to know?","volume":"101","author":"Chong","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jmv.2010.08.004_bib0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1378\/chest.08-0693","article-title":"Executive Summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Hirsh","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jmv.2010.08.004_bib0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-125-2-199607150-00031","article-title":"Thrombocytosis associated with low molecular weight heparin [letter]","volume":"2","author":"Rizzieri","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jmv.2010.08.004_bib0020","doi-asserted-by":"crossref","first-page":"742","DOI":"10.7326\/0003-4819-126-9-199705010-00024","article-title":"Thrombocytosis associated with low molecular weight heparin","volume":"9","author":"Williams","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jmv.2010.08.004_bib0025","first-page":"183","article-title":"Low-molecular-weight heparin and thrombocytosis: a further reason to monitor the platelet count","volume":"12","author":"Anonymous","year":"2003","journal-title":"Prescrire Int"},{"key":"10.1016\/j.jmv.2010.08.004_bib0030","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1592\/phco.26.11.1667","article-title":"Reactive thrombocytosis associated with enoxaparin","volume":"26","author":"Hummel","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jmv.2010.08.004_bib0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0755-4982(06)74521-3","article-title":"Thrombocytosis: adverse effect of heparin treatment","volume":"35","author":"Camou","year":"2006","journal-title":"Presse Med."},{"key":"10.1016\/j.jmv.2010.08.004_bib0040","first-page":"244","article-title":"Heparin-related thrombocytosis","volume":"25","author":"Lepont-Gilardi","year":"2006","journal-title":"J Pharm Clin"},{"key":"10.1016\/j.jmv.2010.08.004_bib0045","first-page":"65","article-title":"Thrombocytosis after prophylactic administration of enoxaparin: unexpected findings in a Polish prospective multicenter trial on the efficacy and safety of enoxaparin in the prevention of postoperative thromboembolism","volume":"1","author":"Ziaja","year":"1999","journal-title":"Int Angiol"},{"key":"10.1016\/j.jmv.2010.08.004_bib0050","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1345\/aph.1A461","article-title":"Low-molecular weight heparins and thrombocytosis","volume":"36","author":"Liautard","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jmv.2010.08.004_bib0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00002018-200326030-00005","article-title":"Utilisation and safety of low molecular weight heparins: prospective observational study in medical patients","volume":"26","author":"Cestac","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.jmv.2010.08.004_bib0060","first-page":"150","article-title":"Effects of heparin on megakaryocytopoiesis. From fundamental data to clinical applications","volume":"148","author":"Bellucci","year":"1997","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.jmv.2010.08.004_bib0065","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1365-2141.1994.tb05080.x","article-title":"Fraxiparin, a low molecular weight heparin, stimulates megakaryocytopoiesis in vitro and in vivo in mice","volume":"88","author":"Shen","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmv.2010.08.004_bib0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1097-4652(199607)168:1<97::AID-JCP12>3.0.CO;2-M","article-title":"Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growths regulators","volume":"168","author":"Han","year":"1996","journal-title":"J Cell Physiol"}],"container-title":["Journal des Maladies Vasculaires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398049910003641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398049910003641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T20:11:27Z","timestamp":1759954287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0398049910003641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0398049910003641"],"URL":"https:\/\/doi.org\/10.1016\/j.jmv.2010.08.004","relation":{},"ISSN":["0398-0499"],"issn-type":[{"type":"print","value":"0398-0499"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La thrombocytose au cours des traitements par h\u00e9parine de bas poids mol\u00e9culaire\u00a0: une situation plus fr\u00e9quente qu\u2019on ne le croit\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Journal des Maladies Vasculaires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmv.2010.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}